PubRank

O Di Munno

Author PubWeight™ 22.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006 2.79
2 A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000 2.47
3 Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2008 1.26
4 The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol 1981 1.15
5 Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab 1998 1.11
6 Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 1985 1.06
7 Long-term prospective study of osteoporotic patients treated with percutaneous vertebroplasty after fragility fractures. Osteoporos Int 2010 0.94
8 Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979 0.88
9 Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study. J Clin Densitom 2007 0.87
10 Lung function in essential mixed cryoglobulinemia: a short-term follow-up. Clin Rheumatol 1989 0.87
11 Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients. Clin Exp Rheumatol 2007 0.84
12 Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men: the ESOPO study. Osteoporos Int 2005 0.82
13 Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience. Clin Exp Rheumatol 2011 0.81
14 [Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia]. Minerva Med 1994 0.81
15 Liver involvement in essential mixed cryoglobulinemia. Ric Clin Lab 1980 0.81
16 Glucocorticoid-induced osteoporosis: 2013 update. Reumatismo 2014 0.81
17 [YKL 40: marker of disease activity in rheumatoid arthritis?]. Minerva Med 2000 0.80
18 Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 2000 0.80
19 Effects of short-term, high dose, heparin therapy on biochemical markers of bone metabolism. Clin Rheumatol 1995 0.78
20 Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description. Clin Exp Rheumatol 2010 0.77
21 Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years. Osteoporos Int 1997 0.77
22 Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study. Clin Exp Rheumatol 2007 0.76
23 [Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis]. Reumatismo 2002 0.75
24 [Common variable immunodeficiency. Autopsy and clinical findings in a case]. Arch De Vecchi Anat Patol 1981 0.75
25 [Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. Reumatismo 2007 0.75
26 Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcif Tissue Int 1997 0.75
27 [Minor connectivitis and the mixed connective tissue disease]. Minerva Med 1980 0.75
28 Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 2017 0.75
29 [Short-term effects of salmon calcitonin rectal administration in women with involutive osteoporosis]. Minerva Endocrinol 1994 0.75
30 [Renal tubular acidosis in essential mixed cryoglobulinemia]. Minerva Nefrol 1981 0.75
31 Multicentric Castleman's disease in a patient with primary Sjögren's syndrome. Rheumatol Int 1993 0.75
32 Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone Miner 1992 0.75